🇺🇸 FDA
Patent

US 6846911

Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian CD97 α subunit

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6846911 (Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian CD97 α subunit) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00